au.\*:("SANDS, Bruce E")
Results 1 to 19 of 19
Selection :
Outcome of surgical Versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's diseaseGUTIERREZ, Alexandra; LEE, Hang; SANDS, Bruce E et al.The American journal of gastroenterology. 2006, Vol 101, Num 10, pp 2283-2289, issn 0002-9270, 7 p.Article
Possible association between isotretinoin and inflammatory bowel diseaseREDDY, Deepa; SIEGEL, Corey A; SANDS, Bruce E et al.The American journal of gastroenterology. 2006, Vol 101, Num 7, pp 1569-1573, issn 0002-9270, 5 p.Article
Selective leukocyte apheresis for the treatment of inflammatory bowel diseaseABREU, Maria T; PLEVY, Scott; SANDS, Bruce E et al.Journal of clinical gastroenterology. 2007, Vol 41, Num 10, pp 874-888, issn 0192-0790, 15 p.Article
Effects of growth hormone secretion on body composition in patients with Crohn's diseaseKATZNELSON, Laurence; FAIRFIELD, Wesley P; ZEIZAFOUN, Nebras et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 11, pp 5468-5472, issn 0021-972X, 5 p.Article
Risk of early surgery for Crohn's disease: Implications for early treatment strategiesSANDS, Bruce E; ARSENAULT, Joanne E; COOPER, Herbert L et al.The American journal of gastroenterology. 2003, Vol 98, Num 12, pp 2712-2718, issn 0002-9270, 7 p.Article
Variation in severity assessment and initial mesalamine dose selection for ulcerative colitis in community practiceSANDS, Bruce E; KILGORE, Karl M; BLOOMFELD, Richard S et al.Journal of clinical gastroenterology. 2006, Vol 40, Num 7, pp 587-591, issn 0192-0790, 5 p.Article
A Pooled Analysis of I nfections, Mal ignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel DiseaseLICHTENSTEIN, Gary R; RUTGEERTS, Paul; SANDBORN, William J et al.The American journal of gastroenterology. 2012, Vol 107, Num 7, pp 1051-1063, issn 0002-9270, 13 p.Article
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)TRAVIS, Simon P. L; SCHNELL, Dan; MARTEAU, Phillippe R et al.Gut. 2012, Vol 61, Num 4, pp 535-542, issn 0017-5749, 8 p.Article
The I nflammatory Bowel Diseases and Ambient Air Pollution: A Novel AssociationKAPLAN, Gilaad G; HUBBARD, James; KORZENIK, Joshua et al.The American journal of gastroenterology. 2010, Vol 105, Num 11, pp 2412-2419, issn 0002-9270, 8 p.Article
Transition of Adolescents With Inflammatory Bowel Disease From Pediatric to Adult Care : A Survey of Adult GastroenterologistsHAIT, Elizabeth J; BARENDSE, Renée M; ARNOLD, Janis H et al.Journal of pediatric gastroenterology and nutrition. 2009, Vol 48, Num 1, pp 61-65, issn 0277-2116, 5 p.Article
Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's DiseaseTHIA, Kelvin T; SANDBORN, William J; LEWIS, James D et al.The American journal of gastroenterology. 2008, Vol 103, Num 12, pp 3123-3131, issn 0002-9270, 9 p.Article
The Risk of Developing Crohn's Disease After an Appendectomy : A Meta-AnalysisKAPLAN, Gilaad G; JACKSON, Timothy; SANDS, Bruce E et al.The American journal of gastroenterology. 2008, Vol 103, Num 11, pp 2925-2931, issn 0002-9270, 7 p.Article
Infliximab for induction and maintenance therapy for ulcerative colitisRUTGEERTS, Paul; SANDBORN, William J; DE VILLIERS, Willem J. S et al.The New England journal of medicine. 2005, Vol 353, Num 23, pp 2462-2476, issn 0028-4793, 15 p.Article
Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseSANDBORN, William J; FEAGAN, Brian G; FOX, Irving et al.The New England journal of medicine. 2013, Vol 369, Num 8, pp 711-721, issn 0028-4793, 11 p.Article
Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisFEAGAN, Brian G; RUTGEERTS, Paul; FOX, Irving et al.The New England journal of medicine. 2013, Vol 369, Num 8, pp 699-710, issn 0028-4793, 12 p.Article
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialHUEBER, Wolfgang; SANDS, Bruce E; KARCZEWSKI, Jacek et al.Gut. 2012, Vol 61, Num 12, pp 1693-1700, issn 0017-5749, 8 p.Article
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's DiseaseSANDBORN, William J; GASINK, Christopher; GHOSH, Subrata et al.The New England journal of medicine. 2012, Vol 367, Num 16, pp 1519-1528, issn 0028-4793, 10 p.Article
Infliximab maintenance therapy for fistulizing Crohn's diseaseSANDS, Bruce E; ANDERSON, Frank H; RACHMILEWITZ, Daniel et al.The New England journal of medicine. 2004, Vol 350, Num 9, pp 876-885, issn 0028-4793, 10 p.Article
Risk factors for colon ischemiaWALKER, Alexander M; BOHN, Rhonda L; CALI, Clorinda et al.The American journal of gastroenterology. 2004, Vol 99, Num 7, pp 1333-1337, issn 0002-9270, 5 p.Article